June 21, 2017: The Fourth Annual Rosenman Symposium

20170621_QB3_181.jpg

At the Rosenman Institute we’re here to support medtech startups. We connect entrepreneurs to the resources and expertise they need to commercialize their technologies. Helping innovators forge connections is why we’ve brought our legendary symposium back for a fourth year. Join us in San Francisco on June 21 to learn from leaders in the field, meet CEOs of exciting early-stage companies, and get insight on how industry forms strategic partnerships with startups.

Rosenman Innovators

During the symposium, we'll hear lightning presentations from 10 entrepreneurs: the Rosenman Innovators. The Rosenman Innovators are the entrepreneurs selected as finalists for the Medtech Track of the QB3 Life Science Pitch Summits. Rosenman Innovators are eligible to be chosen to receive a wide range of valuable medtech services (valued at $250k) including lab time, prototyping, and design support, plus cash prizes. Learn more

Event Sponsors

Speakers

Agenda

1:00 pm     Registration

1:30 pm     Welcome: Christine Winoto, Deputy Director, QB3; Director, Rosenman Institute

1:35 pm     Steve Hetts, UCSF: "Hitting Cancer Hard While Limiting Collateral Damage"

1:55 pm     Company Demos: 2017 Rosenman Innovators

2:05 pm     Justin Roberts, Medtronic: "TAVR: Developing and Cultivating a Breakthrough Therapy"

2:25 pm     Company Demos: 2017 Rosenman Innovators

2:35 pm     Break

3:00 pm     Robert Gaunt, University of Pittsburgh: "Wired Brains: Technology & Neuroscience for Rehabilitation"

3:20 pm     Company Demos: 2017 Rosenman Innovators

3:30 pm     Richard Rapoza, Abbott Vascular: "Unexpected Consequences in Clinical Trial Design"

3:50 pm     Showcase: Rosenman Innovation Award Startups

4:00 pm     Break

4:30 pm     Panel Discussion: "Game of Thrones: Strategic Acquisition in Medtech"
                      Lisa Suennen, GE Ventures (moderator)
                      Jennifer Kozak, Johnson & Johnson
                      Chris Eso, Medtronic
                      Virginia Giddings, Stryker

5:30 pm     Reception

June 22, 2016: "Medical Devices Reimagined"

Every day, engineers integrate new technology into medical devices. But with the pace of advances in technology and discovery, the potential for devices now far outstrips the state of the art. It is essential for us to reimagine the possibilities. Where better to reimagine devices than the Rosenman Symposium, held at UCSF Mission Bay? Together, we can speed the development of exciting technologies to improve the lives of patients.

Event Sponsor

 
 

Award Sponsors

 
 
 

Speakers

Agenda

1:00 pm     Registration

1:30 pm     Welcome: Christine Winoto, Deputy Director, QB3; Director, Rosenman Institute

1:35 pm     Brian Otis, CTO, Verily: "Smart Contact Lenses: Diabetes and Beyond"

1:55 pm     Showcase: Rosenman Innovation Award Startups

2:00 pm     Darrell Johnson, Vice President and General Manager for the Cardiac Rhythm and Heart Failure (CRHF) Connected Care business, Medtronic: "Is the Patient Ready for the Revolution?"

2:20 pm     Showcase: Rosenman Innovation Award Startups

2:25 pm     Break

2:50 pm     Dr. Adam Gazzaley, UCSF, Akili Interactive & JAZZ Venture Partners: "Technology meets Neuroscience -- a Vision of the Future of Brain Health"

3:10 pm     Showcase: Rosenman Innovation Award Startups

3:15 pm     Bryan Larson, Vice President of Product Excellence, Stryker: "Not Invented Here"

3:35 pm     Showcase: Rosenman Innovation Award Startups

3:40 pm     Break

4:10 pm     Showcase: Rosenman Innovation Award Startups
                 Presentation of the prizes sponsored by IO Life Sciences, Surpass, and Smith & Nephew

4:30 pm     Panel Discussion: "Technology that Will Amaze Us in Coming Years"
                      Ron Leuty, San Francisco Business Times (moderator)
                      Darrell Johnson, Medtronic
                      Firat Yazicioglu, GlaxoSmithKline
                      Reza Zadno, Novartis Venture Fund
                      Hanson Gifford, The Foundry

5:30 pm     Reception

June 24, 2015: "How Precision Medicine is Transforming Medical Devices"

Precision medicine is transforming the field of medical devices. How can engineers, investors, clinicians, and medical device professionals anticipate the future? Our June symposium brings Bay Area stakeholders together to share insights and discuss how entrepreneurs can bring new technologies to market for the benefit of patients.
Check out the speaker lineup below!

Sponsors

Speakers

Agenda

1:00-1:30 Registration

1:30-1:45 Welcome

Reg Kelly, PhD, Director, QB3 and Christine Leong Connors, Managing Director, JP Morgan Chase

1:45-2:10 "The Transformation of Medicine by Next Generation Sequencing" 

Richard Klausner, MD, Senior Vice President & Chief Medical Officer, Illumina

2:10-2:35 "Triple-Aiming at Coronary Disease: Bringing Software and Big Data to Bear on a #1 Killer" 

Campbell Rogers, MD, CMO, HeartFlow

2:35-3:00 Break

3:00-3:25 "Devices to Help Patients Unlearn Neuropsychiatric Conditions" 

Edward Chang, MD, Associate Professor in Residence of Neurological Surgery and Physiology, UCSF

3:25-3:50 "3D Bio-Printing: Enabling Functional, Architecturally Correct Human Tissues for Research and Treatment" 

Eric David, MD, JD, Chief Strategy Officer, Organovo

3:50-4:20 Break

4:20-4:25 Presentation of the Rosenman Innovation Awards

4:25-5:25 Panel discussion: "Technologies of Interest to Investors in the Near Future" 

Moderated by Casey McGlynn, Partner, WSGR
Zach Bogue, Co-Managing Partner, Data Collective
Juan-Pablo Mas, Partner, Action Potential Venture Capital
Bruce Rosengard, MD, FRCS, Chief Technology Officer, Global Surgery, Johnson & Johnson

5:30-6:30 Reception

June 4, 2014: "Empowering the Next Generation of Medical Innovators"

The route for taking a medical device from idea to product generally isn’t smooth. Surgeons know what problems they need solved, but they often know little about bioengineering. Engineers are great at building products, but often don't know whether a device is needed or wanted in the clinic.

That’s why we created the Rosenman Institute, a UCSF-based initiative devoted to medical device innovation. The Institute, named for the late Dan Rosenman, a biomedical engineer, is a collaboration between QB3, the UCSF Department of Surgery, the UCSF Department of Bioengineering and Therapeutic Sciences, and medical device professionals. Our goal is to connect physician innovators with engineering expertise and business support to accelerate medical device innovation.

This symposium will inspire clinicians and engineers to innovate; introduce the resources available at the Rosenman Institute; and enable entrepreneurs to share their stories and their perspectives on the future of medical device innovation. It will also provide an opportunity for networking with entrepreneurs, physicians, investors, biomedical engineers, scientists, mentors and representatives of major device companies.

Sponsors

Speakers

Agenda

Registration & Networking

Welcome

Reg Kelly, PhD, Director, QB3
Kathy Giacomini, PhD, Chair, UCSF Department of Bioengineering and Therapeutic Sciences
Hanmin Lee, MD, Surgeon in Chief, UCSF Benioff Children's Hospital San Francisco

Tribute to Dan Rosenman

Panel Discussion: "From Ideas to Commercialization: Lessons Learned"

The Rosenman Fellows
Moderated by Reg Kelly

"The Innovator's Dilemma in Surgery"

Ken Drazan, MD, Head, Johnson & Johnson Innovation Center in California

"The Radically Changing Landscape for Medical Technology Innovation"

Paul Yock, MD, Director, Biodesign, Stanford University

Panel Discussion: "Insights on Early Stage Funding"

Ned Scheetz, Managing Director, Aphelion Capital
Allan May, Chairman & Founder, Life Science Angels
Moderated by Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati

"So You Want to Be an Entrepreneur?"

Frank Litvack, MD, serial entrepreneur

Reception & Networking